Acrongenomics, Inc. (AGNM) is a publicly traded company that focuses on developing in and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-oriented applications.